The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 28, 2022
Filed:
Jun. 15, 2016
Applicants:
Prism Pharma Co., Ltd., Yokohama, JP;
Eisai R&d Management Co., Ltd., Tokyo, JP;
Inventors:
Takenao Odagami, Yokohama, JP;
Hiroyuki Kouji, Yokohama, JP;
Yoichi Ozawa, Tsukuba, JP;
Yusaku Hori, Tsukuba, JP;
Assignees:
PRISM Pharma Co., Ltd., Kanagawa, JP;
Eisai R&D Management Co., Ltd., Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/675 (2006.01); A61K 45/06 (2006.01); A61K 39/395 (2006.01); A61K 31/53 (2006.01); A61K 31/519 (2006.01); C07K 16/28 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/675 (2013.01); A61K 31/519 (2013.01); A61K 31/53 (2013.01); A61K 39/395 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07K 16/2818 (2013.01);
Abstract
The present invention aims to provide a therapeutic drug for cancer having a superior treatment effect. A cancer treatment using a CBP/catenin inhibitor and an immune checkpoint inhibitor in combination not only increases a treatment effect on cancer, but also enables an effective treatment of cancer patients showing low sensitivity when an immune checkpoint inhibitor is used alone.